Previous 10 | Next 10 |
The following slide deck was published by Ironwood Pharmaceuticals, Inc. in conjunction with their 2022 Q2 earnings call. For further details see: Ironwood Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call Presentation
Ironwood Pharmaceuticals press release ( NASDAQ: IRWD ): Q2 Non-GAAP EPS of $0.21 misses by $0.09 . Revenue of $97.23M (-6.5% Y/Y) misses by $6.28M . Adjusted EBITDA was $56.0 million in the second quarter of 2022, compared to $65.2 million in the second quarte...
– LINZESS (Iinaclotide) EUTRx prescription demand growth in Q2 2022 increased 9% year-over-year – – GAAP net income of $37 million and adjusted EBITDA of $56 million; ended Q2 2022 with $504 million in cash and cash equivalents – –...
Ironwood Pharmaceuticals ( NASDAQ: IRWD ) is scheduled to announce Q2 earnings results on Thursday, August 4th, before market open. The consensus EPS Estimate is $0.30 (-11.8% Y/Y) and the consensus Revenue Estimate is $103.51M (-0.5% Y/Y). Over the last 2 years, IRWD ...
Ironwood Pharmaceuticals ( NASDAQ: IRWD ) is trading down 7% after AbbVie ( ABBV ) Friday morning reported Q2 2022 revenue of Linzess (linaclotide) -- which is marketed by both companies -- that came in below analyst consensus estimates. Linzess and Constella (...
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced it will host its second quarter 2022 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, August 4, 2022. Individuals interested in participating in the call should dial (888) 330-2384 (U.S. ...
DiDi Global DIDI +61% as Beijing looks to end cybersecurity probe. Yumanity Therapeutics YMTX+42% on all-stock merger with Kineta; lead product sale to J&J for $26M. Full Truck Alliance YMM +26% as Beijing looks to end cybersecurity probe. Kanzhun Limited BZ ...
Keurig Dr Pepper, VICI Properties and ON Semiconductor Set to Join S&P 500; Others to Join S&P MidCap 400, and S&P SmallCap 600 Keurig Dr Pepper, VICI Properties and ON Semiconductor Set to Join S&P 500; Others to Join S&P MidCap 400, and S&P SmallCap 600...
Big changes are afoot in the S&P 500, as Dow Jones Indices shuffles three companies in and out of the index. ON Semiconductor (NASDAQ:ON) is up 6.5% after hours; VICI Properties (NYSE:VICI) is up 6.2%; and Keurig Dr Pepper (NASDAQ:KDP) is up 5.4% postmarket as all three companies make the...
– Other Studies Highlight Impact of Linaclotide in Adult and Pediatric Populations, Highlight Disease Burden – Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, presented new findings during the 2022 Digestive Disease Week ...
News, Short Squeeze, Breakout and More Instantly...
Ironwood Pharmaceuticals Inc. Company Name:
IRWD Stock Symbol:
NASDAQ Market:
Ironwood Pharmaceuticals Inc. Website:
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that Sravan Emany, Chief Financial Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 9:00 a.m. ET at the Marriott Marquis in New York City. A live webcast of I...
2024-05-22 07:30:10 ET Wells Fargo analyst issues OVERWEIGHT recommendation for IRWD on May 22, 2024 05:13AM ET. The previous analyst recommendation was Overweight. IRWD was trading at $6.78 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
2024-05-22 07:00:07 ET Mohit Bansal from Wells Fargo issued a price target of $14.00 for IRWD on 2024-05-22 05:13:00. The adjusted price target was set to $14.00. At the time of the announcement, IRWD was trading at $6.78. The overall price target consensus is at $16.00 ...